Dr. Bharat Pothuri is a board-certified gastroenterologist and the founder of GastroDoxs. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
He examines your risk factors (IV drug use, unlicensed tattoos/piercings, transfusions before 1992), inquires about any of the symptoms, including epigastric discomfort, fatigue, jaundice and makes an abdominal examination to look at enlargement or tenderness of the liver.
We request HCV antibody and RNA tests to prove infection and liver functionality tests (ALT, AST) to determine the active liver damage.
There are some cases when a percutaneous liver biopsy measures inflammation and fibrosis, or endoscopy examines varices in the case of the raised suspicion of portal hypertension.
Dr. Pothuri has treated more than 1.3K patients, helping individuals improve their digestive health and overall well-being through expert, personalized care.
With over 20 years of experience, GastroDoxs has been a trusted provider of gastroenterology care, focusing on delivering the best outcomes for patients
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
Hepatitis C is a liver infection that is caused by hepatitis C virus (HCV). When untreated it may result in chronic liver disease.
It is transmitted via blood-to-blood contact- most often through sharing of needles, unsterilized medical equipment, or blood transfusion until 1992.
Many people have no symptoms. In their case, they are fatigue, jaundice, nausea, abdominal pains and black urine.
The diagnosis is done by blood tests, an antibody test in order to screen and HCV RNA test to confirm a state of active infection.
Over 95 percent of cases can be treated in 812 weeks with direct-acting antiviral (DAA) drugs having few side effects.
Prevention comprises of sharing needles, screening blood products and standard precautions within healthcare facilities.
Yes. Advanced fibrosis or cirrhotic patients should have hepatology follow-up and screening of liver cancer throughout their lifespan.
